Adel Shahnam

The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy

Sarah Badaoui, Adel Shahnam, Ross A. McKinnon et al. · Translational Lung Cancer Research · 2022 · 34 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Generative AI chatbots for reliable cancer information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models

Bradley D. Menz, Natansh D. Modi, Ahmad Y. Abuhelwa et al. · European Journal of Cancer · 2025 · 28 citations · Full text

Computing, Computer Science, Oncology +16

Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies

Adel Shahnam, Nadia Hitchen, Udit Nindra et al. · European Journal of Cancer · 2023 · 20 citations

Medicine, Biostatistics, Oncology +15

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer

Natansh D. Modi, N.O. Danell, R.N.A. Perry et al. · ESMO Open · 2022 · 19 citations · Full text

Medicine, Oncology, Breast Oncology +11

Elevated neutrophil‐to‐lymphocyte ratio (<scp>NLR</scp>) is associated with poorer progression‐free survival in unresectable stage <scp>III NSCLC</scp> treated with consolidation durvalumab

Udit Nindra, Adel Shahnam, Samuel Xavier Stevens et al. · Thoracic Cancer · 2022 · 16 citations · Full text

Medicine, Hematology, Oncology +12